Cerity Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Sell
52,210
-1,237
-2% -$24.5K ﹤0.01% 1994
2026
Q1
$1.03M Buy
53,447
+301
+0.6% +$5.93K ﹤0.01% 1849
2025
Q4
$1.01M Buy
53,146
+24,055
+83% +$446K ﹤0.01% 1722
2025
Q3
$542K Buy
29,091
+10,405
+56% +$194K ﹤0.01% 1920
2025
Q2
$345K Buy
18,686
+7,885
+73% +$140K ﹤0.01% 2072
2025
Q1
$189K Buy
+10,801
New +$182K ﹤0.01% 2233
2024
Q4
Sell
-18,361
Closed -$342K 2571
2024
Q3
$342K Buy
+18,361
New +$310K ﹤0.01% 1978
2024
Q2
Sell
-10,923
Closed -$161K 2386
2024
Q1
$161K Sell
10,923
-5,284
-33% -$73.2K ﹤0.01% 2150
2023
Q4
$232K Buy
+16,207
New +$230K ﹤0.01% 1653

Other funds holding SBRA

Cerity Partners's SBRA Position: Q2 2026 in Review

Cerity Partners reduced its Sabra Healthcare REIT (SBRA) stake by 2.3% in Q2 2026, selling an estimated $24.5K and leaving 52,210 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

Cerity Partners first reported a position in SBRA in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.03M in Q1 2026. 429 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Cerity Partners held 52,210 shares of Sabra Healthcare REIT worth $1.02M as of Q2 2026.
  • Cerity Partners sold 1,237 Sabra Healthcare REIT shares in Q2 2026, an estimated $24.5K.
  • Sabra Healthcare REIT made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1994 holding.
  • Cerity Partners first reported a position in Sabra Healthcare REIT in Q4 2023 and has held it in 9 quarters since.
  • Cerity Partners's Sabra Healthcare REIT position peaked at $1.03M in Q1 2026.
  • 429 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.